001     144745
005     20240826140055.0
024 7 _ |a 10.1055/s-0035-1552630
|2 doi
024 7 _ |a 0302-4350
|2 ISSN
024 7 _ |a 1431-4886
|2 ISSN
024 7 _ |a 1438-9428
|2 ISSN
037 _ _ |a DZNE-2020-00195
082 _ _ |a 610
100 1 _ |a Fischer, A.
|0 P:(DE-2719)2000047
|b 0
|e First author
|u dzne
245 _ _ |a Epigenetik – neue Erkenntnisse zum Verständnis neurodegenerativer Erkrankungen | Epigenetic Mechanisms in Neurodegenerative Diseases
260 _ _ |a Stuttgart
|c 2015
|b Thieme
264 _ 1 |3 online
|2 Crossref
|b Georg Thieme Verlag KG
|c 2015-09-14
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1724673602_18923
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Epigenetics describes the various structures and functions of the DNA-protein matrix (chromatin), which regulate gene expression beyond the DNA sequence. The epigenome determines the differences in the development of genetically identical cells and individuals (mono-zygotic twins). Epigenetic features such as direct biochemical modifications of DNA (methylation) are affected by environmental conditions (famine, early life stress) and are inherited in a modified form, without alteration of the DNA sequence. The analysis of epigenetic processes, in particular DNA methylation, modifications of the DNA-binding proteins, and the functions of the non-coding microRNA, opens an unexpectedly complex field of environment-gene interactions that affect the individual patterns of disease symptoms as well as effects and side effects of many drugs.The study of the epigenome hold the promise of new diagnostic and possibly therapeutic perspectives also for the two most common neurodegenerative diseases, namely Alzheimerʼs and Parkinsonʼs disease.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Schneider, A.
|0 P:(DE-2719)2812035
|b 1
|u dzne
700 1 _ |a Wüllner, U.
|0 P:(DE-2719)2000056
|b 2
|e Last author
|u dzne
773 1 8 |a 10.1055/s-0035-1552630
|b : Georg Thieme Verlag KG, 2015-09-14
|n 07
|p 393-401
|3 journal-article
|2 Crossref
|t Aktuelle Neurologie
|v 42
|y 2015
|x 0302-4350
773 _ _ |a 10.1055/s-0035-1552630
|g Vol. 42, no. 07, p. 393 - 401
|0 PERI:(DE-600)2056721-2
|n 07
|p 393-401
|t Aktuelle Neurologie
|v 42
|y 2015
|x 0302-4350
909 C O |p VDB
|o oai:pub.dzne.de:144745
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2000047
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2812035
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2000056
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 1
914 1 _ |y 2015
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2019-12-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2019-12-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2019-12-21
920 1 _ |0 I:(DE-2719)1011302
|k AG Wüllner
|l Biomarker Parkinson's Disease
|x 0
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer ; AG Fischer
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 1
920 1 _ |0 I:(DE-2719)1440011
|k AG Schneider Göttingen
|l Translational Dementia Research Göttingen
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1011302
980 _ _ |a I:(DE-2719)1410002
980 _ _ |a I:(DE-2719)1440011
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21